A phase 2 clinical trial is underway.

PositionScience scene - Brief article

A phase 2 clinical trial is underway to test an experimental DNA vaccine designed to protect against disease caused by Zika infection. The vaccine was developed by the National Institute of Allergy and Infectious Diseases, Bethesda, Md. The trial is enrolling at least 2,490 healthy participants in areas of confirmed...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT